UBC, a provider of commercialization services, has acquired Examoto, a risk evaluation and mitigation strategy company.

Examoto develops and deploys the operation of REMS services in the pharmaceutical market.

Patrick Lindsay, UBC’s CEO, said, “We are excited by the compelling opportunities this acquisition presents to expand the industry’s leading one-stop shop for full-service REMS programs. The combination of Examoto’s technology-driven approach with UBC’s scientific, technological, and operational expertise will ensure the most efficient delivery of successful REMS programs to patients and clients.”